Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis
Abstract
A combination of transcriptomics, proteomics, and phosphoproteomics reveals therapeutic targets in colitis.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 27, 2018
- Source ID
- 10.1126/scisignal.aan3580
Entities
People
- Amanda Edwards
- Douglas A. Lauffenburger
- Douglas K Brubaker
- Jesse Lyons
- Joseph L. Kissil
- Katherine R Baldwin
- Kevin M Haigis
- Lucia Suarez-Lopez
- Myriam Boukhali
- Phaedra C Ghazi
- Samantha Dale Strasser
- Vijay Yajnik
- Wilhelm Haas
- Yi-Jang Lin
Organizations
- Army Research Office
- Cancer Research Institute
- Crohn's & Colitis Foundation of America
- Harvard Medical School
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- National Institutes of Health
- National Science Foundation
- Scripps Research
- United States Department of Defense